Universitätsklinikum Schleswig-Holstein (UKSH) Institut für Humangenetik
88 capabilities
Accredited since January 2026
Verified Apr 2026
One of 3,039 in Germany
Details
Ratzeburger Allee 160
Lübeck 23538 , Germany
Lübeck 23538 , Germany
Accreditation
Active
DAkkS
D-ML-13069-18-01
Specialises in human genetics testing including chromosome analysis, CNV analysis, and related molecular investigations on blood, tissue, and cellular samples. The laboratory operates under flexible accreditation permitting procedure development and modification.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13069-18-01
Status
ActiveSince
29 January 2026
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (88)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| Erworbener Chromosomensatz | erworbener Chromosomensatz | Biocompatibility (ISO 10993) |
| (AR) | SBMA (AR) | Food Safety Testing |
| (HTT) | Huntington (HTT) | Food Safety Testing |
| AITL (TET2, DNMT3A, RHOA | AITL (TET2, DNMT3A, RHOA | Food Safety Testing |
| Aderhautmelanom (GNAQ Exon | Aderhautmelanom (GNAQ Exon | Food Safety Testing |
| Aderhautmelanom, erblich (BAP1, MBD4), SNV | Aderhautmelanom, erblich (BAP1, MBD4), SNV | Food Safety Testing |
| Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR), , SNV | Adrenogenitale Syndrom (CYP11A1, STAR, HSD3B2, CYP17A1, CYP11B1, POR), , SNV | Food Safety Testing |
| Akute myeloische Leukämie/ | Akute myeloische Leukämie/ | Food Safety Testing |
| Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5) | Food Safety Testing |
| Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5), , SNV | Albinismus (TYR, OCA2, TYRP1, SLC45A2, SLC24A5), , SNV | Food Safety Testing |
| CLL (TP53, NOTCH1 Exon 34, SF3B1 | CLL (TP53, NOTCH1 Exon 34, SF3B1 | Food Safety Testing |
| CMML (TET2, ASXL1 Exon 13, SRSF2 | CMML (TET2, ASXL1 Exon 13, SRSF2 | Food Safety Testing |
| DRPLA (ATN1) | DRPLA (ATN1) | Food Safety Testing |
| Desaminase-Mangel (AMPD1 | Desaminase-Mangel (AMPD1 | Food Safety Testing |
| Exon 1, RUNX1, NRAS, KRAS, SETBP1), SNV | Exon 1, RUNX1, NRAS, KRAS, SETBP1), SNV | Food Safety Testing |
| Exon 13-16, BIRC3, MYD88 | Exon 13-16, BIRC3, MYD88 | Food Safety Testing |
| FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 | FLT3 (TKD, ITD), CEBPA, TP53, ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, IDH1 | Food Safety Testing |
| FMR1) | Fra(X)-Syndrom, FXTAS (FMR1) | Food Safety Testing |
| Friedreich Ataxie (FXN) | Friedreich Ataxie (FXN) | Food Safety Testing |
| GNA11 Exon 4/5, SF3B1 p.Arg625), SNV | GNA11 Exon 4/5, SF3B1 p.Arg625), SNV | Food Safety Testing |
| Huntington-like (TBP, JPH3) | Huntington-like (TBP, JPH3) | Food Safety Testing |
| Myelodysplastisches Syndrom (FLT3- | Myelodysplastisches Syndrom (FLT3- | Food Safety Testing |
| Myelodysplastisches Syndrom/ | Myelodysplastisches Syndrom/ | Food Safety Testing |
| Spinocerebelläre Ataxien (SCA 1, 3, 4, 6, 7, 8, 10, 12, 17) | Spinocerebelläre Ataxien (SCA 1, 3, 4, 6, 7, 8, 10, 12, 17) | Food Safety Testing |
| p.Arg172), , SNV | p.Gly17, IDH2 p.Arg172), , SNV | Food Safety Testing |
| (APC, MUTYH) | (APC, MUTYH) | Molecular Diagnostics / PCR |
| (APC, MUTYH), SNV | (APC, MUTYH), SNV | Molecular Diagnostics / PCR |
| (CDH1), SNV | (CDH1), SNV | Molecular Diagnostics / PCR |
| (CYP21A2) | 21-Hydroxylasemangel (CYP21A2) | Molecular Diagnostics / PCR |
| (GJB2 ) | Schwerhörigkeit (GJB2) | Molecular Diagnostics / PCR |
| (POLD1, POLE, NTHL1, MSH3), SNV | (POLD1, POLE, NTHL1, MSH3), SNV | Molecular Diagnostics / PCR |
| (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2), SNV | (SF3B1, TP53, NPM1, FLT3 (TKD, ITD), ASXL1, BCOR, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, STAG2, U2AF1 und TET2), SNV | Molecular Diagnostics / PCR |
| (SHOX ) | Kleinwuchs (SHOX) | Molecular Diagnostics / PCR |
| (STK11) | Peutz-Jeghers-Syndrom (STK11) | Molecular Diagnostics / PCR |
| (TP53), SNV | (TP53), SNV | Molecular Diagnostics / PCR |
| (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA), SNV | (TP53, NRAS, KRAS, BRAF, BIRC3, JAK3, PDGFRA), SNV | Molecular Diagnostics / PCR |
| 21-Hydroxylasemangel (CYP21A2), SNV | 21-Hydroxylasemangel (CYP21A2), SNV | Molecular Diagnostics / PCR |
| Cowden-Syndrom (PTEN), SNV | Cowden-Syndrom (PTEN), SNV | Molecular Diagnostics / PCR |
| Deletion/Duplication Syndrom | Deletion/Duplication Syndrom | Molecular Diagnostics / PCR |
| DiGeorge; 22q11.2 | DiGeorge; 22q11.2 | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB), SNV | Ehlers-Danlos-Syndrom (COL3A1, COL5A1, COL5A2, TNXB), SNV | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Ehlers-Danlos-Syndrom (COL3A1, TNXB) | Molecular Diagnostics / PCR |
| Entwicklungsstörung | Entwicklungsstörung | Molecular Diagnostics / PCR |
| GJB6) | Schwerhörigkeit (GJB6) | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53), SNV | HBOC (BRCA1, BRCA2, ATM, BARD1, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53), SNV | Molecular Diagnostics / PCR |
| HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | HBOC (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D) | Molecular Diagnostics / PCR |
| HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM) | Molecular Diagnostics / PCR |
| HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM), SNV | HNPCC (MLH1, MSH2, MSH6, PMS2, EPCAM), SNV | Molecular Diagnostics / PCR |
| Hereditäre Dystonie (THAP1) | Hereditäre Dystonie (THAP1) | Molecular Diagnostics / PCR |
| Hereditäres Magenkarzinom | Hereditäres Magenkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Magenkarzinom (CDH1) | Hereditäres Magenkarzinom (CDH1) | Molecular Diagnostics / PCR |
| Kleinwuchs (SHOX), SNV | Kleinwuchs (SHOX), SNV | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom (TP53, CHEK2) | Li-Fraumeni-Syndrom (TP53, CHEK2) | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom (TP53, CHEK2), SNV | Li-Fraumeni-Syndrom (TP53, CHEK2), SNV | Molecular Diagnostics / PCR |
| Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2), SNV | Loeys-Dietz-Syndrom (SMAD3, TGFB2, TGFBR1, TGFBR2), SNV | Molecular Diagnostics / PCR |
| Marfan Syndrom (FBN1, TGFBR2) | Marfan-Syndrom (FBN1, TGFBR2) | Molecular Diagnostics / PCR |
| Marfan-Syndrom (FBN1, TGFBR2), SNV | Marfan-Syndrom (FBN1, TGFBR2), SNV | Molecular Diagnostics / PCR |
| Multiples Myelom/Plasmozytom | Multiples Myelom/Plasmozytom | Molecular Diagnostics / PCR |
| Myelodysplastisches Syndrom | Myelodysplastisches Syndrom | Molecular Diagnostics / PCR |
| Neurofibromatose (NF1) | Neurofibromatose (NF1) | Molecular Diagnostics / PCR |
| Neurofibromatose (NF1), SNV | Neurofibromatose (NF1), SNV | Molecular Diagnostics / PCR |
| Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS), SNV | Noonan-Syndrom (PTPN11, SOS1, RAF1, RIT1, BRAF, KRAS), SNV | Molecular Diagnostics / PCR |
| Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Pankreaskarzinom (BRCA1, BRCA2, CDKN2A, STK11, PALB2, ATM, CHEK2, APC, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM, VHL) | Molecular Diagnostics / PCR |
| Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Parkinson (PARK2, SNCA, PINK1, UCHL1, PARK7, ATP13A2, LRRK2) | Molecular Diagnostics / PCR |
| Peutz-Jeghers-Syndrom (STK11), SNV | Peutz-Jeghers-Syndrom (STK11), SNV | Molecular Diagnostics / PCR |
| Polyposis, adenomatös: FAP / MAP | Polyposis, adenomatös: FAP, MAP | Molecular Diagnostics / PCR |
| Polyposis, juvenil: JPS (BMPR1A, SMAD4) | Polyposis, juvenil: JPS (BMPR1A, SMAD4), SNV | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM) | Molecular Diagnostics / PCR |
| Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM), SNV | Prostatakarzinom (BRCA1, BRCA2, CHEK2, PALB2, ATM), SNV | Molecular Diagnostics / PCR |
| RNU4-2 assoziierte | RNU4-2 assoziierte | Molecular Diagnostics / PCR |
| Rett-Syndrom (MECP2) | Rett-Syndrom (MECP2) | Molecular Diagnostics / PCR |
| Rett-Syndrom (MECP2), SNV | Rett-Syndrom (MECP2), SNV | Molecular Diagnostics / PCR |
| Sotos-Syndrom (NSD1), SNV | Sotos-Syndrom (NSD1), SNV | Molecular Diagnostics / PCR |
| Standort: Albert-Schweitzer-Campus | Standort: Albert-Schweitzer-Campus | Molecular Diagnostics / PCR |
| Tumorpanel (APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTCH1, PTCH2, PTEN, RAD51C, RAD51D, SMAD4, STK11, SUFU, TP53, VHL), SNV | Tumorpanel (APC, ATM, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTCH1, PTCH2, PTEN, RAD51C, RAD51D, SMAD4, STK11, SUFU, TP53, VHL), SNV | Molecular Diagnostics / PCR |
| p.Arg132 und IDH2 p.Arg140 und | p.Arg132 und IDH2 p.Arg140 und | Molecular Diagnostics / PCR |
| p.Val617Phe und Exon 12, CALR | p.Val617Phe und Exon 12, CALR | Molecular Diagnostics / PCR |
| -TKD, NPM1 Exon 11) | -TKD, NPM1 Exon 11) | Other |
| 15-17), SNV | 15-17), SNV | Other |
| Exon 9, MPL Exon 10), SNV | Exon 9, MPL Exon 10), SNV | Other |
| ITD/LM) | ITD/LM) | Other |
| LGL (STAT3 Exon 21, STAT5B Exon | LGL (STAT3 Exon 21, STAT5B Exon | Other |
| MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53), SNV | MPL, TET2, ASXL1, EZH2, DNMT3A, IDH1, IDH2, SRSF2, SF3B1, U2AF1, ZRSR2, CBL, KRAS, NRAS, STAG2, TP53), SNV | Other |
| MYD88 p.Leu265Pro), SNV | MYD88 p.Leu265Pro), SNV | Other |
| Myeloproliferative Neoplasie (JAK2 | Myeloproliferative Neoplasie (JAK2 | Other |
| c.133C>T) | c.133C>T) | Other |
| p.Leu265Pro), SNV | p.Leu265Pro), SNV | Other |